Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Epidemics
Recent news which mentions Epidemics
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
CDC extends Covid restrictions for cruise ship industry to January
October 26, 2021
Tags
Transportation
Pandemics
US Economy
From
CNBC.com News
Harvard professors warn that war-torn countries will miss global vaccine goals in 2022
October 25, 2021
Tags
Politics
Epidemics
Business
From
CNBC.com News
Moderna says its Covid vaccine generates strong immune response in 6- to 11-year-olds
October 25, 2021
Tags
Business News
Policy
Health care industry
From
CNBC.com News
Covid vaccine boosters are now available. Here's who's eligible for Pfizer, Moderna and J&J's shots
October 23, 2021
Tags
Policy
Business News
Pandemics
From
CNBC.com News
U.S. officials keep close watch on the 'delta plus' Covid mutation as it spreads in the U.K.
October 22, 2021
Tags
Disease outbreaks
Politics
Epidemics
From
CNBC.com News
CDC panel unanimously endorses Moderna and J&J Covid boosters, sending to director for final approval
October 21, 2021
Tags
Business
Epidemics
Politics
From
CNBC.com News
CDC says these are the most common side effects people report after getting Moderna, J&J boosters
October 21, 2021
Tags
Biotech and Pharmaceuticals
Breaking News: Business
U/S/ Economy
From
CNBC.com News
Watch live: CDC panel to vote on Moderna and J&J Covid booster shots
October 21, 2021
Tags
Johnson & Johnson
Biotechnology
World News
From
CNBC.com News
FDA clears Johnson & Johnson and Moderna booster shots for millions of people
October 20, 2021
Tags
U/S/ Economy
BioNTech SE
Breaking News: Business
From
CNBC.com News
WHO warns of rise in Covid cases across Europe for third consecutive week as restrictions are eased
October 20, 2021
Tags
Biotechnology
World News
US: News
From
CNBC.com News
CDC study shows Pfizer Covid vaccine is 93% effective against hospitalization in 12- to 18-year-olds
October 19, 2021
Tags
U/S/ Economy
Breaking News: Business
Biotech and Pharmaceuticals
From
CNBC.com News
J&J Covid vaccine adds $502 million to third-quarter sales
October 19, 2021
Tags
Health care industry
Pandemics
Policy
From
CNBC.com News
Colin Powell was vaccinated against Covid, but suffered from a cancer that makes the shots less effective
October 18, 2021
Tags
Business
Epidemics
Politics
From
CNBC.com News
Risk of mRNA Covid booster causing heart inflammation in young adults continues to worry scientists, Dr. Ofer Levy says
October 15, 2021
Tags
Biotech and Pharmaceuticals
Breaking News: Business
U/S/ Economy
From
CNBC.com News
Scientists question FDA on 'scant' J&J booster data and speedy review
October 15, 2021
Tags
Disease outbreaks
Politics
Epidemics
From
CNBC.com News
FDA panel unanimously recommends J&J Covid booster shots to millions of Americans
October 15, 2021
Tags
Politics
Pfizer Inc
Epidemics
From
CNBC.com News
FDA panel unanimously recommends Moderna Covid booster shots for at risk adults
October 14, 2021
Tags
Health & Science
Biotechnology
World News
From
CNBC.com News
Biden to pick Obama FDA head Califf to lead agency through Covid, report says
October 14, 2021
Tags
Disease outbreaks
Politics
Epidemics
From
CNBC.com News
Alaska doctors forced to ration life-sustaining treatments as Covid patients clog up hospitals
October 14, 2021
Tags
Health & Science
World News
Biotechnology
From
CNBC.com News
Watch live: FDA advisory panel to vote on Moderna Covid booster shots
October 14, 2021
Tags
Moderna Inc
Pandemics
Health care industry
From
CNBC.com News
J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests
October 13, 2021
Tags
Epidemics
Pfizer Inc
Politics
From
CNBC.com News
White House calls on pediatricians in kids' Covid vaccine rollout starting as early as next month
October 13, 2021
Tags
Biotechnology
World News
US: News
From
CNBC.com News
WHO says global Covid deaths fell to lowest level in a year last week
October 13, 2021
Tags
World News
Biotechnology
Coronavirus
From
CNBC.com News
FDA scientists strike favorable tone on J&J Covid booster shots ahead of vote this week
October 13, 2021
Tags
Business News
Policy
Health care industry
From
CNBC.com News
FDA staff doesn't take stance on Moderna Covid booster shots, says two doses are enough to protect against severe disease
October 12, 2021
Tags
Disease outbreaks
Business
Epidemics
From
CNBC.com News
U.S. moves closer to clearing Moderna and J&J Covid booster shots this week
October 11, 2021
Tags
Biotech and Pharmaceuticals
Breaking News: Business
BioNTech SE
From
CNBC.com News
Merck asks FDA to authorize antiviral Covid pill for emergency use
October 11, 2021
Tags
Business News
Policy
Health care industry
From
CNBC.com News
UN Secretary calls unequal distribution of Covid vaccines across globe immoral and stupid
October 07, 2021
Tags
Policy
Business News
Health care industry
From
CNBC.com News
Latin America and Caribbean Islands have vaccinated just 37% of populations against Covid, WHO officials say
October 06, 2021
Tags
Health & Science
AstraZeneca PLC
US: News
From
CNBC.com News
CDC director warns the U.S. is at risk of a severe flu season this year
October 06, 2021
Tags
Disease outbreaks
Politics
Epidemics
From
CNBC.com News
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.